openPR Logo
Press release

Global Wilson’s Disease Treatment Market: Data Highlighting Major Vendors, Promising Regions, Anticipated Growth Forecast To 2025 | Key Players Noblepharma Co., Ltd., Wilson Therapeutics, Merck & Co., Inc., Teva Pharmaceuticals USA, Inc. and Tsumura & C

01-25-2019 11:02 AM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Global Wilson’s Disease Treatment Market,

Global Wilson’s Disease Treatment Market,

Wilson’s disease is a genetic disorder caused by the loss of function of the ATP7B copper-binding protein that leads to impaired copper transport and excretion, which results in accumulation of free copper in the bloodstream that results in damage of liver, brain, and other organs. As Wilson’s disease is hard to differentiate from other serious hepatic or neurologic condition that result in less number of patient to be diagnosed than the actual prevalence of Wilson’s disease. Wilson’s disease is characterized by the degree of accumulation of free copper in liver and the brain. Whereas, the patients that suffer from Wilson’s disease can either be asymptomatic or can have one or more clinical symptoms which can vary in type and its severity that include liver disease, neurologic manifestations and psychiatric disturbances. The symptoms for Wilson’s disease may include abdominal pain, lack of appetite, fatigue, jaundice, problems with speech, swallowing or physical coordination and uncontrolled movements or muscle stiffness.

For In depth Information Get Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/526

Wilson disease is suspected in the individual of age 3 - 60 years, whereas the chance of child inheriting autosomal recessive mutation from both the parent by gene mutation is 25% or one in four ratio.

The global Wilson's disease treatment market was valued at US$ 392.0 million in 2016 and is expected to witness a robust CAGR of 6.0% during the forecast period (2017-2025).

Market Dynamics:

Rising incidence of Wilson’s disease is due to increase in the population worldwide as Wilson’s disease is a rare genetic disorder which, is expected to favor the demand for Wilson’s disease treatment market around the globe.

According to the European Association for the study of liver (EASL) in 2011 published that Wilson’s disease is a genetic disorder that is found worldwide and is recognized to be more common than previous, with a gene frequency of 1 in 90 -150 and an incidence that is 1 in 30,000 and more than 500 distinct mutations are described in the Wilson’s gene from which 380 have a confirmed role in the pathogenesis of the disease. Whereas, European Association also stated in year 2011 that Wilson’s disease accounts for 6 - 12% of all patient with acute liver failure who are referred for emergency transplantation.

Market Taxonomy:

This report segments the Wilson’s disease treatment market on basis of treatment type and the Distribution channel. On basis of treatment type, market is categorized into Medications and others. Among these medications segment dominates the Wilson’s disease treatment market throughout the forecast period. Further medication segment is sub-categorized into D-Penicillamine, Trientine, Zinc and Tetrathiomolybdate where D-penicillamine dominates the medication segment. On the basis of the distribution channel Wilson’s disease treatment market is divided into Hospitals pharmacies, Government distribution channel, retail and e-pharmacies among which hospital pharmacies dominates the market throughout the forecast period. Last segment of the market is by geography which includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Among all regions, North America contributes major market share supported by increased incidence rate of Wilson’s disease and growing inclination of the populace towards its treatment.

Rapid advancements in technology allowing for early detection driving growth of the Wilson’s disease treatment market:

North America accounts for the largest share in the global Wilson’s disease treatment market, followed by Europe. This is mainly attributed due to rapid growth in aging population in these regions. Asia Pacific is expected to emerge as a fast growing market for Wilson’s disease over the forecast period. Increasing population in China and India position these as highly lucrative markets for Wilson’s disease treatment. Increase in health expenditure on healthcare further fuels growth of Wilson’s disease treatment market in the region. The market is expected to show high growth rate in Asia Pacific region over the forecast period as Asia consist of 60% of the world’s current population and as Wilson’s disease is a hereditary disease the chance of expansion of this disease is more in Asia Pacific region. According to National Institute on Aging in 2010 it was estimated that 524 million people were aged 65 or older that is 8% of the world's population and by 2050, which is expected to nearly triple the number to 1.5 billion, representing 16% of the world's population. This above mentioned statistics is expected favor the growth of Wilson’s disease treatment market.

Increase in awareness regarding Wilson’s disease is expected to fuel the Wilson’s disease treatment market in near future:

There are various organization and association working to create the awareness regarding Wilson’s disease for example, Wilson’s disease association is a volunteer organization striving to promote the well-being of the patients with Wilson’s disease where they offer the latest information about disease and its symptoms and treatment. Moreover Wilson’s disease association supports research and clinical investigation for Wilson’s disease.

Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/market-insight/wilsons-disease-treatment-market-526

Furthermore, manufacturers also significantly supports the Wilson’s disease awareness programs for example, in 2016, Valeant pharmaceutical announced company’s commitment to improve the lives of Wilson’s disease patients around the world, whereas Valeant has agreed to provide US$ 100,000 to fund enhanced patient awareness and research into the Wilson’s disease.

Competitive Analysis:

Some major players operating in the Wilson’s disease treatment market are Valeant Pharmaceuticals International, Inc., Noblepharma Co., Ltd., Wilson Therapeutics AB, Kadmon Holdings, Inc., Merck & Co., Inc., VHB Life Science Ltd., Teva Pharmaceuticals USA, Inc. and Tsumura & Co.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Wilson’s Disease Treatment Market: Data Highlighting Major Vendors, Promising Regions, Anticipated Growth Forecast To 2025 | Key Players Noblepharma Co., Ltd., Wilson Therapeutics, Merck & Co., Inc., Teva Pharmaceuticals USA, Inc. and Tsumura & C here

News-ID: 1533253 • Views: 332

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Wilson

Corporate Training Services Market Is Booming Worldwide | Wilson Learning Worldw …
Corporate Training Services Market: The extensive research on Corporate Training Services Market, by Qurate Research is a clear representation on all the essential factors that are expected to drive the market considerably. Thorough study on Corporate Training Services Market helps the buyers of the report, customers, the stakeholders, business owners, and stockholders to understand the market in detail. The updated research report comprises key information on the market, such as
Tennis Racquet Strings Market Wilson, Babolat, HEAD
UpMarketResearch offers a latest published report on Global Tennis Racquet Strings Market industry analysis and forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains XX pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Tennis Racquet Strings Market research report delivers a close watch on leading competitors with strategic analysis,
Wilson Disease Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Wilson Disease - Pipeline Review, H1 2017, provides an overview of the Wilson Disease (Genetic Disorders) pipeline landscape. Wilson disease is a rare autosomal recessive inherited disorder of copper metabolism that is characterized by excessive deposition of copper in the liver, brain, and other tissues. Symptoms include abdominal pain, jaundice, problems with speech, swallowing and muscle stiffness. Treatment includes chelators and Vitamin E
Wilson Realty is now Wilson & Associates Real Estate and Property Management
PRESS RELEASE Contact: Linda J. Wilson, Broker Phone: 727-398-5700 Linda@WilsonAssociatesRealty.com WILSON REALTY IS NOW WILSON & ASSOCIATES REAL ESTATE AND PROPERTY MANAGEMENT North Redington Beach, FL November 6, 2017 – Linda J. Wilson, Broker/Owner of Wilson Realty announced this week that the company has officially changed its name to Wilson & Associates Real Estate and Property Management as of November 1, 2017. Linda Wilson, Broker/Owner explained that the new name reflects the evolving focus
Tennis Apparel and Footwear 2017 Global Market by Types, Countries, Manufacturer …
Tennis Apparel and Footwear Market 2017 Report Details: Wiseguyreports.Com Adds “Tennis Apparel and Footwear Market - Market Size, Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Global Tennis Apparel and Footwear market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including NIKE Adidas Wilson HEAD LiNing Prince Champion Yonex Kappa Babolat Dunlop Flia Decathlon
Global Volleyball Market- Train, Under Armour, Tachikara, Wilson
Global Volleyball Market report 2017 is an in-depth research on the current situation of the Volleyball industry. The Scope of the Volleyball research report: The Global Volleyball Market primarily includes a basic overview of the Volleyball industry. It also includes Volleyball definitions, classifications and applications. It segments the market by applications, types, regions, competitive players and also analyzes Volleyball market size, business share and Volleyball revenue, price and sales. The report mainly